Patents matching “treatment”

US 6171788

Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

The Regents of the University of California · Granted Jan 9, 2001 · Expires Jan 4, 2021

US 6165484

EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6166079

DFMO for the treatment or prevention of cervical intraepithelial neoplasia

The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6166008

Treatment of schizophrenia with ampakines and neuroleptics

The Regents of the University of California · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6162432

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 19, 2000 · Expires Dec 14, 2020

US 6159958

Treatment or prophylaxis of retinal pathology and spinal cord injury

The United States of America as represented by the Secretary of the Army · Granted Dec 12, 2000 · Expires Dec 7, 2020

US 6156321

Tissue factor methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Dec 5, 2000 · Expires Nov 30, 2020

US 6155266

Method for treatment of cancer and infectious disease

Maxim Pharmaceuticals, Inc. · Granted Dec 5, 2000 · Expires Nov 30, 2020

US 6150398

Methods for the treatment of cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 21, 2000 · Expires Nov 16, 2020

US 6146653

Pharmaceutical preparation and a method for the treatment of diabetes

Diataranz Limited · Granted Nov 14, 2000 · Expires Nov 9, 2020

US 6147060

Treatment of carcinomas using squalamine in combination with other anti-cancer agents

Magainin Pharmaceuticals Inc. · Granted Nov 14, 2000 · Expires Nov 9, 2020

US 6147051

Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction

Takeda Chemical Industries Ltd. · Granted Nov 14, 2000 · Expires Nov 9, 2020

US 6147123

Treatment and prevention of hepatic disorders

The Regents of the University of California · Granted Nov 14, 2000 · Expires Nov 9, 2020

US 6140366

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Oct 31, 2000 · Expires Oct 26, 2020

US 6136307

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Oct 24, 2000 · Expires Oct 19, 2020

US 6132724

Allelic polygene diagnosis of reward deficiency syndrome and treatment

The University of Texas System AMD Board of Regents · Granted Oct 17, 2000 · Expires Oct 12, 2020

US 6132729

Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

US 6132730

Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

US 6133278

Use of quinone and hydroquinone derivatives for the treatment of cachexia

Takeda Chemical Industries Ltd. · Granted Oct 17, 2000 · Expires Oct 12, 2020

US 6133320

Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors

The Board of Regents of the University of Texas System · Granted Oct 17, 2000 · Expires Oct 12, 2020

US 6117906

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Sep 12, 2000 · Expires Sep 7, 2020

US 6114397

Gossypol for the treatment of cancer

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 5, 2000 · Expires Aug 31, 2020

US 6110461

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Aug 29, 2000 · Expires Aug 24, 2020

US 6103709

Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs and methods for treatment of vitamin D diseases

The Regents of the University of California · Granted Aug 15, 2000 · Expires Aug 10, 2020